A clinical neuroscientist investigated the long-term efficacy of atypical and typical antipsychotics for different symptom groups in patients diagnosed with schizophrenia. The findings from the 12-month clinical trial are summarised in Table 1.
| Symptom group | Percentage of patients showing significant reduction with atypical antipsychotics | Percentage of patients showing significant reduction with typical antipsychotics |
|---|---|---|
| Patients presenting with negative symptoms | 48% | 12% |
| Patients presenting with positive symptoms | 74% | 74% |
What do the data in Table 1 suggest about the relative effectiveness of atypical and typical antipsychotics in the treatment of schizophrenia?
14 exam-style questions on AQA A Level Psychology Drug therapy for schizophrenia. Each one has a worked solution and a mark scheme showing where the marks go.